JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Artificial Intelligence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capsules", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemistry, Pharmaceutical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gelatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Technology, Pharmaceutical", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutical Sciences, University of Maryland-Baltimore, 21201, Baltimore, MD", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "Department of Pharmaceutical Sciences, University of Maryland-Baltimore, 21201, Baltimore, MD"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilson", 
        "givenName": "Wendy I.", 
        "id": "sg:person.01065516667.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065516667.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Computer Science and Electrical Engineering, University of Maryland Baltimore County, 21250, Maltiomre, MD", 
          "id": "http://www.grid.ac/institutes/grid.266673.0", 
          "name": [
            "Department of Computer Science and Electrical Engineering, University of Maryland Baltimore County, 21250, Maltiomre, MD"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peng", 
        "givenName": "Yun", 
        "id": "sg:person.01136741416.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136741416.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutical Sciences, University of Maryland-Baltimore, 21201, Baltimore, MD", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "Department of Pharmaceutical Sciences, University of Maryland-Baltimore, 21201, Baltimore, MD"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Augsburger", 
        "givenName": "Larry L.", 
        "id": "sg:person.01153104621.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153104621.46"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1011986823850", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007767460", 
          "https://doi.org/10.1023/a:1011986823850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1016212804288", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037126380", 
          "https://doi.org/10.1023/a:1016212804288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1007578321803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000308030", 
          "https://doi.org/10.1023/a:1007578321803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015843527138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002628904", 
          "https://doi.org/10.1023/a:1015843527138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/pt040226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018669844", 
          "https://doi.org/10.1208/pt040226"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-09", 
    "datePublishedReg": "2005-09-01", 
    "description": "The aim of this project was to expand a previously developed prototype expert network for use in the analysis of multiple biopharmaceutics classification system (BCS) class II drugs. The model drugs used were carbamazepine, chlorpropamide, diazepam, ibuprofen, ketoprofen, naproxen, and piroxicam. Recommended formulations were manufactured and tested for dissolution performance. A comprehensive training data set for the model drugs was developed and used to retrain the artificial neural network. The training and the system were validated based on the comparison of predicted and observed performance of the recommended formulations. The initial test of the system resulted in high error values, indicating poor prediction capabilities for drugs other than piroxicam. A new data set, containing 182 batches, was used for retraining. The percent of the test batches were used for cross-validation, resulting in models with R2\u226570%. The comparison of observed performance to the predicted performance found that the system predicted succcessfully. The hybrid network was generally able to predict the amount of drug dissolved within 5% for the model drugs. Through validation, the system was proven to be capable of designing formulations that met specific drug performance criteria. By including parameters to address wettability and the intrinsic dissolution characteristics of the drugs, the hybrid system was shown to be suitable for analysis of multiple BCS class II drugs.", 
    "genre": "article", 
    "id": "sg:pub.10.1208/pt060356", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1023420", 
        "issn": [
          "1530-9932"
        ], 
        "name": "AAPS PharmSciTech", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "intelligent hybrid system", 
      "comprehensive training data", 
      "artificial neural network", 
      "poor prediction capability", 
      "training data", 
      "neural network", 
      "expert networks", 
      "hybrid network", 
      "highest error value", 
      "hybrid system", 
      "new data set", 
      "data sets", 
      "network", 
      "prediction capability", 
      "observed performance", 
      "error values", 
      "performance criteria", 
      "performance", 
      "system", 
      "capability", 
      "test batches", 
      "set", 
      "project", 
      "training", 
      "initial test", 
      "validation", 
      "generalization", 
      "model", 
      "data", 
      "batch", 
      "formulation", 
      "use", 
      "comparison", 
      "amount", 
      "analysis", 
      "development", 
      "parameters", 
      "criteria", 
      "characteristics", 
      "values", 
      "aim", 
      "test", 
      "percent", 
      "formulation development", 
      "model drug", 
      "BCS class II drug", 
      "dissolution performance", 
      "class II drug", 
      "dissolution characteristics", 
      "Biopharmaceutics Classification System class II drug", 
      "wettability", 
      "amount of drug", 
      "drugs", 
      "ibuprofen", 
      "ketoprofen", 
      "naproxen", 
      "carbamazepine", 
      "piroxicam", 
      "chlorpropamide", 
      "diazepam"
    ], 
    "name": "Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development", 
    "pagination": "e449-e457", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034895274"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1208/pt060356"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16354004"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1208/pt060356", 
      "https://app.dimensions.ai/details/publication/pub.1034895274"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_411.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1208/pt060356"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

181 TRIPLES      21 PREDICATES      97 URIs      84 LITERALS      13 BLANK NODES